Personalized Dendritic Cell Vaccines—Recent Breakthroughs and Encouraging Clinical Results

With the advent of combined immunotherapies, personalized dendritic cell (DC)-based vaccination could integrate the current standard of care for the treatment of a large variety of tumors. Due to their proficiency at antigen presentation, DC are key coordinators of the innate and adaptive immune sys...

Descripción completa

Detalles Bibliográficos
Autores principales: Mastelic-Gavillet, Beatris, Balint, Klara, Boudousquie, Caroline, Gannon, Philippe O., Kandalaft, Lana E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470191/
https://www.ncbi.nlm.nih.gov/pubmed/31031762
http://dx.doi.org/10.3389/fimmu.2019.00766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470191/
https://www.ncbi.nlm.nih.gov/pubmed/31031762
http://dx.doi.org/10.3389/fimmu.2019.00766

Ejemplares similares